LeConte Wealth Management
TMO icon

LeConte Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

LeConte Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$312K Buy
462
+6
+1% +$3.56K 0.17% 117
2026
Q2 		$229K Buy
456
+7
+2% +$3.36K 0.12% 138
2026
Q1 		$221K Buy
449
+25
+6% +$13.6K 0.14% 132
2025
Q4 		$246K Sell
424
-35
-8% -$19.8K 0.16% 102
2025
Q3 		$223K Buy
+459
New +$214K 0.15% 115

Other funds holding TMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

LeConte Wealth Management's TMO Position: Q3 2026 in Review

LeConte Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q3 2026, buying an estimated $3.56K and bringing the position to 462 shares worth $312K. The position accounts for 0.17% of the portfolio, ranked #117.

LeConte Wealth Management first reported a position in TMO in Q3 2025 and has held it in 5 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • LeConte Wealth Management held 462 shares of Thermo Fisher Scientific worth $312K as of Q3 2026.
  • LeConte Wealth Management bought 6 Thermo Fisher Scientific shares in Q3 2026, an estimated $3.56K.
  • Thermo Fisher Scientific made up 0.17% of LeConte Wealth Management's portfolio in Q3 2026, its #117 holding.
  • LeConte Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 5 quarters since.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.